Aethlon Medical
AEMD
3 hedge funds and large institutions have $2.3M invested in Aethlon Medical in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.14% more ownership
Funds ownership: 5.15% → 5.3% (+0.14%)
0% more funds holding
Funds holding: 3 → 3 (0)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $26K
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$16K |
| 2 |
AIG
American International Group
New York
|
-$5K |
| 3 |
Tower Research Capital (TRC)
New York
|
-$5K |
AEMD Hedge Fund Activity: Q2 2016 in Review
3 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2016, worth a combined $2.3M — up 8.7% from $2.12M a quarter earlier.
Fund positioning in AEMD was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Thompson Davis & Co, cutting an estimated $16K.
- 3 institutional investors held Aethlon Medical (AEMD) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $2.3M of Aethlon Medical stock for Q2 2016, up 8.7% quarter-over-quarter.
- 0 funds opened new Aethlon Medical positions in Q2 2016 and 0 closed out.
- The largest Aethlon Medical seller in Q2 2016 was Thompson Davis & Co, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2016.